Support the news

FDA Questions Safety And Marketing Of Cannabidiol, Known As CBD03:45
Download

Play

The FDA holds a hearing Friday on CBD, a popular extract of the cannabis plant. The FDA sent warning letters to companies about illegal marketing practices, and says it needs more data about safety.

+Join the discussion
TwitterfacebookEmail

Support the news